1,000
Participants
Start Date
January 11, 2021
Primary Completion Date
November 4, 2023
Study Completion Date
January 30, 2024
Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
Hospital de Braga, EPE, Braga
Centro Hospitalar e Universitário de Coimbra - Hospital Geral & Hospital Universitário de Coimbra, Coimbra
Centro Hospitalar Universitário do Algarve - Hospital de Faro, Faro
Hospital Prof. Doutor Fernando Fonseca, Amadora
Centro Hospitalar Lisboa Ocidental - Hospital de Santa Cruz, Carnaxide
Centro Hospitalar Lisboa Central - Hospital de Santa Marta, Lisbon
Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria, Lisbon
Centro Hospitalar Universitário do Porto, EPE - Hospital de Santo António, Porto
Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia
Hospital Garcia de Orta, Almada
Centro Hospitalar de Setúbal, Setúbal
Hospital do Espírito Santo de Évora, EPE, Evora
Collaborators (1)
AstraZeneca
INDUSTRY
Cardiovascular Centre of Universidade de Lisboa (CCUL)
UNKNOWN
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
OTHER